My understanding is that 25-30% profit with most of the US sales going through the WIC programme is very optimistic - maybe 5% at best?
My educated guess is that A2M management haven’t been asleep at the wheel but made an offer under the FDA exemption to supply a limited number of tins at a minimum margin. They would surely rather direct product to the high margin China market at this point while keeping a door open in the US but under specific terms.
Of course they could all be out playing golf but I think the former is more likely. Come Aug 29th I guess we’ll know more!
Ann: Deferral of FDA consideration of enforcement discretion, page-103
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.62 |
Change
-0.130(1.93%) |
Mkt cap ! $4.840B | |||
| Open | High | Low | Value | Volume |
| $6.73 | $6.73 | $6.59 | $5.120M | 767.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 15201 | $6.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.62 | 8365 | 7 |
View Market Depth
| Last trade - 13.38pm 19/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |